阿斯利康新冠药试验结果:能将重症或死亡风险降低50%
阿斯利康也披露新冠药物试验结果:能将重症或死亡风险降低50%
https://wallstreetcn.com/articles/3642048
https://www.ft.com/content/17cf953b-38b5-4862-814f-ad51f1066f19
https://wallstreetcn.com/articles/3642048
https://www.ft.com/content/17cf953b-38b5-4862-814f-ad51f1066f19